Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) induced Coronavirus Disease - 19 (COVID-19) cases have been increasing at an alarming rate (7.4 million positive cases as on June 11 2020), causing high mortality (4,17,956 deaths as on June 11 2020) and economic loss (a 3.2% shrink in gl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Beeraka, Narasimha M., Sadhu, Surya P., Madhunapantula, SubbaRao V., Rao Pragada, Rajeswara, Svistunov, Andrey A., Nikolenko, Vladimir N., Mikhaleva, Liudmila M., Aliev, Gjumrakch
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531039/
https://ncbi.nlm.nih.gov/pubmed/33072093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.552925
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados